Bio-Techne: OverT Bio receives $120,000 G-Rex grant from ScaleReady in partnership with Wilson Wolf Manufacturing to propel solid tumour cell therapy advancements

OverT Bio, a New York based biotechnology company developing effective and safe cellular therapies for solid tumours, announced that it has been awarded a $120,000 G-Rex Grant from ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady.